scholarly journals Pyruvate Dehydrogenase-E1α Deficiency Presenting as Recurrent Demyelination: An Unusual Presentation and a Novel Mutation

2012 ◽  
pp. 107-111 ◽  
Author(s):  
Pratibha Singhi ◽  
Linda De Meirleir ◽  
Willy Lissens ◽  
Sunit Singhi ◽  
Arushi Gahlot Saini
2008 ◽  
Vol 146A (20) ◽  
pp. 2657-2662 ◽  
Author(s):  
Hala Mégarbané ◽  
Céline Cluzeau ◽  
Christine Bodemer ◽  
Sylvie Fraïtag ◽  
Myrna Chababi-Atallah ◽  
...  

2003 ◽  
Vol 53 (2) ◽  
pp. 273-277 ◽  
Author(s):  
Runu Dey ◽  
Manuele Mine ◽  
Isabelle Desguerre ◽  
Abdelhamid Slama ◽  
Loic Van Den Berghe ◽  
...  

1995 ◽  
Vol 6 (3) ◽  
pp. 274-275 ◽  
Author(s):  
Fumie Takakubo ◽  
David R. Thorburn ◽  
Ruth M. Brown ◽  
Garry K. Brown ◽  
Hans-Henrik M. Dahl

1993 ◽  
Vol 2 (11) ◽  
pp. 1961-1962 ◽  
Author(s):  
Fumle Takakubo ◽  
David R. Thorburn ◽  
Hans-Henrik ◽  
M. Dahl

2019 ◽  
Vol 41 (3) ◽  
pp. e193-e196 ◽  
Author(s):  
Faten Tinsa ◽  
Manel Ben Romdhane ◽  
Hela Boudabous ◽  
Imen Bel Hadj ◽  
Ines Brini ◽  
...  

2005 ◽  
Vol 25 (8) ◽  
pp. 3286-3294 ◽  
Author(s):  
Mathieu Gabut ◽  
Manuèle Miné ◽  
Cécile Marsac ◽  
Michèle Brivet ◽  
Jamal Tazi ◽  
...  

ABSTRACT Pyruvate dehydrogenase (PDH) complex deficiency is a major cause of lactic acidosis and Leigh's encephalomyelopathies in infancy and childhood, resulting in early death in the majority of patients. Most of the molecular defects have been localized in the coding regions of the E1α PDH gene. Recently, we identified a novel mutation of the E1α PDH gene in a patient with an encephalopathy and lactic acidosis. This mutation, located downstream of exon 7, activates a cryptic splice donor and leads to the retention of intronic sequences. Here, we demonstrate that the mutation results in an increased binding of the SR protein SC35. Consistently, ectopic overexpression of this splicing factor enhanced the use of the cryptic splice site, whereas small interfering RNA-mediated reduction of the SC35 protein levels in primary fibroblasts from the patient resulted in the almost complete disappearance of the aberrantly spliced E1α PDH mRNA. Our findings open the exciting prospect for a novel therapy of an inherited disease by altering the level of a specific splicing factor.


2010 ◽  
Vol 52 (4) ◽  
pp. e181-e183 ◽  
Author(s):  
Satoshi Sato ◽  
Hiroaki Ioi ◽  
Yasuyo Kashiwagi ◽  
Hisashi Kawashima ◽  
Tasuku Miyajima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document